View Item 
        •   Utrecht University Student Theses Repository Home
        • UU Theses Repository
        • Theses
        • View Item
        •   Utrecht University Student Theses Repository Home
        • UU Theses Repository
        • Theses
        • View Item
        JavaScript is disabled for your browser. Some features of this site may not work without it.

        Browse

        All of UU Student Theses RepositoryBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

        Assessing cardiac, hepatic, and renal safety of hospitalized Covid-19 patients treated with: remdesivir: a retrospective cohort study.

        Thumbnail
        View/Open
        Ajay_Lakhisaran_6998917_Research-report.pdf (407.9Kb)
        Publication date
        2022
        Author
        Lakhisaran, Ajay
        Metadata
        Show full item record
        Summary
        Remdesivir played a major part as a treatment possibility of Covid-19 patients and still is part of treatment guidelines, however, there still are cardiac, hepatic, and renal safety concerns. The main aim of this research was to investigate cardiac-, hepatic and renal-related safety concerns in Covid-19 patients treated with remdesivir. To investigate these safety outcomes a retrospective cohort study was conducted. We included 2554 patients (male: 1449; female: 1105, remdesivir: 584; no-remdesivir: 1970) from the Haga Hospital, Leiden University Medical Center (LUMC), Alrijne Hospital and Haaglanden Medical Center (HMC) from the first of March 2020 until the first of March 2021. Bradycardia was seen in 8.3% of the remdesivir users compared to 6.1% in the no-remdesivir users (OR: 1.21; 95% CI: 0.80-1.83, p= 0.370). Acute kidney injury (AKI) was seen in 4.2% of the remdesivir users in comparison to 5.3% in noremdesivir users (OR: 0.93; 95% CI: 0.54-1.59, p= 0.778). Acute liver injury was seen in 4.3% of the remdesivir users and in 1.1% of the no-remdesivir users (OR: 3.06; 95% CI: 1.62-5.76, p<0.001). Based on these findings there is no need to be concerned about the cardiac and renal outcomes of remdesivir. However, remdesivir still is associated with a higher likelihood on the occurrence of ALI.
        URI
        https://studenttheses.uu.nl/handle/20.500.12932/43329
        Collections
        • Theses
        Utrecht university logo